Prevention of dementia (including Alzheimer's disease);Prävention von Demenz (einschließlich Alzheimer-krankheit)

Gesundheitswesen

Volumn 66, Issue 5, 2004, Pages 346-351

  Kornhuber, Hans Helmut ^a,b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE   (Germany)

Author keywords

Activity; Alzheimer's disease; Dementia; Prevention; Risk factors

Indexed keywords

ALCOHOL; APOLIPOPROTEIN E4; CHOLESTEROL; ESTROGEN; HOMOCYSTEINE; INSULIN;

AGED; ALZHEIMER DISEASE; BRAIN BLOOD FLOW; CANCER; CHOLESTEROL BLOOD LEVEL; COGNITION; CORONARY ARTERY DISEASE; DEMENTIA; DIABETES MELLITUS; DIETARY INTAKE; EDUCATION; ELDERLY CARE; ESTROGEN DEFICIENCY; EUROPE; EXERCISE; GENETIC ANALYSIS; HEART DEATH; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIFE EXPECTANCY; LIFESTYLE; LIPOPROTEIN METABOLISM; MEDITERRANEAN DIET; MICROANGIOPATHY; ONSET AGE; PHYSICAL ACTIVITY; POPULATION GROWTH; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 2942687264     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-812832     Document Type: Review

References (106)

1. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia A quantitative integra tion of the literature. Acta psychiat Scand 1987; 76: 465-479
2. Wiltfang J, Lewczuk P, Kornhuber J. Labordiagnostik. In: Förstl H (Hrsg). Lehrbuch der Gerontopsychiatrie und -psychotherapie, 2. Aufl. Stuttgart, New York: Thieme Verlag KG, 2003: 107-119
3. Bleich S, Wiltfang J, Kornhuber J. Memantine in moderate to severe Alzheimer's disease. N Engl J Med 2003; 349: 609-610
4. Grässel E, Wiltfang J, Spatt J et al. Demenz. In: Stefan H, Mamoli B (Hrsg). Aktuelle Therapie in der Neurologie. Landsberg/Lech: Ecomed, 2002
5. Nee LE, Lippa CF. Alzheimer's disease in 22 twin pairs - 13-year follow-up: hormonal, infectious and traumatic factors. Dementia and Geriatric cognitive disorders 1999; 10: 148-151
6. Christensen K, Vaupel J. Determinants of longevity: Genetic, environmental and medical factors. J Int Med 1996; 240: 333-341
7. Hassler O. Vascular changes in senile brains: a micro-angiographic study. Acta Neuropathol (Berl.) 1965; 5: 40-53
8. Bucht G, Adolfson R, Lithner F et al. Changes in blood glucose and insuline secration in patients with senile dementia of Alzheimer type. Acta Med Skand 1983; 213: 387-292
9. Scheibel AB, Duong T, Jacobs R. Alzheimer's disease as a capillary dementia. Ann Med 1989; 21: 103-107
10. Förstl H, Burns A, Luthart P et al. Demenz und internistische Erkrankungen: die Häufigkeit innerer Krankheiten bei Alzheimer-Demenz, vaskulärer Demenz und anderen dementiellen Erkrankungen. Z Gerontol 1991; 24: 91-93
11. Kornhuber HH, Elsäßer G, Görtler N et al. Zerebrale Mikroangiopathie, eine häufige Ursache psychischer Störungen im höheren Lebensalter: ihre Risikofaktoren, ihre Beziehung zur Makroangiopathie und zur Alzheimer-Demenz. In: Huber G, Gross G (Hrsg), Perspektiven psychiatrischer Forschung und Praxis, Stuttgart: Schattauer, 1994: 109-134
12. Kornhuber HH. Cerebral microangiopathy, anaerobic infection, and the prevention of Alzheimer's disease. Neurol Psychiat Brain Res 1998; 5: 209-212
13. Prince M, Cullen M, Mann A. Risk factors for Alzheimer's disease and dementia: a control study based on the MRC elderly hypertension trial. Neurology 1994; 44: 97-104
14. Hofman A, Ott A, Breteler M et al. Atherosclerosis, apolipoproteine E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997; 349: 151-154
15. Moody DM, Brown WR, Challa VR et al. Cerebral microvascular alterations in aging, leucoaraiosis and Alzheimer's disease. Ann New York Acad Sci 1997; 826: 103-116
16. Skoog I. Vascular aspects in Alzheimer's disease. J Neur Transmiss Suppl 2000; 59: 37-43
17. Skoog I, Gustafson D. Hypertension and related factors in the etiology of Alzheimer's disease. Ann NY Acad Sci 2002; 997: 29-36
18. Breteler MM. Vascular involement in cognitive decline and dementia Epidemiologic evidence from the Rotterdam study and the Rotterdam scan study. Ann NY Acad Sci 2000; 903: 457-465
19. De la Torre JC. Vascular basis of Alzheimer's pathogenesis. Ann NY Acad Sci 2002; 977: 196-215
20. De la Torre JC. Alzheimer's disease as a vascular disorder: nosological evidence. Stroke 2002; 33: 1152-1162
21. Launer LJ. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Research Reviews 2002; 1: 61-77
22. Kalaria RN. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovascular Dis 2003; 13 (2): 48-52
23. Posner HB, Tang MX, Luchsinger J et al. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002; 58: 1175-1181
24. Vermeer SE, Prins ND, den Heijer T et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-1222
25. Beyreuther K. Rationale Strategie zur Diagnostik und Therapie des Morbus Alzheimer - State of the art. In: Zanella F, Kornhuber J (Hrsg). Fortschritte in der Behandlung des Morbus Alzheimer. Neu-Isenburg: LinguaMed Verlag, 2003: 99-119
26. Corder EH, Saunders AM, Strittmatter WJ et al. The apolipoprotein E 4-allele and sexspecific risk of Alzheimer's disease. J Am Med Ass 1995; 273: 373-374
27. Couderc R, Machieux F, Bailleul et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. Stroke 1993; 24: 661-664
28. Frisoni GB, Bianchetti A, Govoni S et al. Association of apolipoprotein E 4 with vascular dementia. J Am Med Ass 1994; 271: 317
29. Pedro-Botet J, Senti M, Nogues X et al. Lipoproteine and apolipoproteine profile in men with ischemic stroke Role of lipoproteine, triglyceride-rich lipoproteine and apolipoproteine E polymorphism. Stroke 1992; 23: 1556-1562
30. Shimano H, Ishibashi S, Murase T et al. Plasma apolipoproteine in patients with multiinfact dementia. Atherosclerosis 1989; 79: 257-260
31. Launer LJ, Ross GW, Petrovitch H et al. Midlife blood pressure und dementia: the Honululu-Asia aging study. Neurobiol of aging 2000; 21: 49-55
32. Kokmen E, Beard CM, Chandra V et al. Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 1991; 41: 1393-1397
33. Knopman D, Boland LL, Mosley T et al. Atherosclerosis risk in community (ARIC) study investigators: Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-48
34. Bovirrat A, Friedland RP, Farrer L et al. Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs. J molec neurosci MN 2002; 19: 239-245
35. Clarke R, Smith AD, Jobst KA et al. Folate, vitamin B 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55: 1449-1455
36. Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-483
37. Hogervorst E, Ribeiro HM, Molyneux A et al. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002; 59: 787-793
38. Mcllroy SP, Dynan KB, Lawson JT et al. Moderately elevated plasma homocysteine, methylenetetrahydofolate reductase genetype, and risk for stroke, vascular dementia, and Alzheimer disease in Nothern Ireland. Stroke 2002; 33: 2351-2356
39. Miller JW, Green R, Mungas DM et al. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 2002; 58: 1471-1475
40. Bleich S, Bleich K, Kropp S et al. Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: a contradiction to the "French paradox"? Alcohol and Alcoholism 2001; 36: 189-192
41. Fratiglioni L, Ahlbom A, Vittanen M et al. Risk factos for late-onset Alzheimer's disease: a population based, case-control study. Ann Neurol 1993; 33: 258-266
42. Yoshitake T, Kiyohara Y, Kato I et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study. Neurology 1995; 45: 1161-1168
43. Shelmet JJ, Reichard GA, Skutches CL et al. Ethanol causes acute inhibition of carbohydrate, fat and protein oxydation and insuline resistance. J Clin Invest 1988: 81: 1137-1145
44. Kornhuber HH, Backhaus B, Kornhuber AW et al. Die Hauptursache von Diabetes (Typ II): der "normale" Alkoholkonsum. Versicherungsmed 1990; 42: 132-142
45. Kornhuber HH. Alkohol - Auch der "normale" Konsum schadet. München: Urban und Vogel, 2001
46. Kornhuber HH. Bluthochdruck und Alkoholkonsum. In: Rosenthal J (Hrsg). Arterielle Hypertonie. Berlin: Springer, 1984: 149-162
47. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Clarendon Press, 1985
48. Brooks PJ. DNA damage, DNA repair, and alcohol toxicity - a review. Alcoholism Clin Exp Res 1997; 21: 1073-1082
49. Puddey IB, Parker M, Beilin LJ et al. Effects of alcohol and caloric restriction on blood pressure and serum lipids in overweight men. Hypertension 1992; 20: 533-554
50. Ling Y, Hefferman M, Buchanan T et al. Effects of alcohol on subjective ratings of prospective and everyday memory deficits. Alcoholism Clin Exp Res 2003; 27: 970-974
51. Ruitenberg A, van Swieten JC, Witteman JCM et al. Alcoholconsumption and risk of dementia: The Rotterdam study. Lancet 2002; 359: 281-286
52. Jepson RG, Fowkes FGR, Donner PT et al. Alcohol intake as a risk factor for peripheral arterial disease in the general population in the Edinburgh Artery Study. Eur J Epidemiol 1995; 11: 9-14
53. Shaper AG, Vannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped course. Lancet 1988; II, 8623: 1267-1273
54. Schimmler W. Über den Einfluß der diabetischen Stoffwechselstörung auf die Arterienelastizität. Arch Kreisl Forschg 1970; 62: 25-55
55. Pate RR, Pratt M, Blair SN et al. Physical activity and public health. A recommendation from the centers for disease control and prevention and the American college of sports medicine. J Am Med Ass 1995; 273: 402-407
56. Villeneuve PJ, Morrison HI, Craig CL et al. Physical activity, physical fitness and risk of dying. Epidemiology 1998; 9: 626-631
57. de Lorgeril M, Salen P, Martin JL et al. Mediterranian diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Circulation 1999; 99: 779-785
58. Panagiotakos DB, Pitzavos C, Kokinos P et al. Consumption of fruits and vegetables in relation to the risk of developing acute coronary syndromes; the CARDIO2000 case-control study. Nutrition J 2003; 2: 2
59. Jarvis GK. Mormon mortality rates in Canada. Soc Biol 1977; 24: 294-302
60. Chatenoud L, Tarani A, La Vecchia C et al. Whole grain food intake and cancer risk. Internat J Cancer 1998; 77: 24-28
61. Terry P, Nyren O, Yuen J. Protective effect of fruits and vegetables on stomach cancer in a cohort of swedish twins. Internat J Cancer 1998; 76: 35-37
62. Grant WB. An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002; 94: 1867-1875
63. Snowdon DA, Kemper SJ, Mortimer JA et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. J Am Med Ass 1996; 275: 528-532
64. Skoog J, Lernfelt B, Landahl S et al. 15-years longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-1145
65. Kokman E, Beard CM, Chandra V et al. Clinical risk factors for Alzheimer's disease: a population based case-control study. Neurology 1991; 41: 1393-1397
66. Shaji S, Promudu K, Abraham T et al. An epidemiological study of dementia in a rural community in Kerala/India. Brit J Psychiat 1996; 168: 745-749
67. Knopman D, Boland LL, Mosley T et al. Atherosclerosis risk in communities study investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-48
68. Kivepelto M, Helkala EL, Laakso MP et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. Brit Med J 2001; 322: 1447-1451
69. Ott A, Stolk RP, Hofman A et al. Association of diabetes mellitus and dementia: The Rotterdam study. Diabetologia 1996; 39: 1392-1397
70. Leibson CL, Rocca WA, Hanson VA et al. Risk of dementia among persons with diabetes mellitus: a population-based cohorte study. Am J Epidemiol 1997; 145: 301-308
71. Ott A, Stolk RP, van Harskamp P et al. Diabetes mellitus and the risk of dementia: The Rotterdam study. Neurology 1999; 53: 1937-1942
72. Curb JD, Rodriguez BL, Abbott RD et al. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology 1999; 52: 971-975
73. Luchsinger JA, Tang MX, Stern Y et al. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohorte. Ann J Epidemiol 2001; 154: 635-641
74. McKnight C, Rockwood K, Awald E et al. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian study of health and ageing. Dement Geriat Cognit Disord 2002; 14: 77-83
75. Bruce DG, Harrington N, Davis WA et al. Fremantle diabetes study. Dementia and its associations in type II diabetes mellitus: the Fremantle diabetes study. Diabet Res Clin Pract 2001; 53: 165-172
76. Forette F, Seux ML, Staesen JA et al. Prevention of dementia in randomized double-blind placebo-controlled systolic hypertension in Europe (SystEur) trial. Lancet 1998; 352: 1347-1351
77. Guo Z, Frattiglioni L, Zhou L et al. Occurence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol 1999; 56: 991-996
78. Launer LJ, Ross GW, Petrovitch H et al. Midlife blood pressure and dementia: the Honolulu-Asia ageing study. Neurobiol Aging 2000; 21: 49-55
79. In't Veld BA, Ruitenberg A, Hofman A et al. Antihypertensive drugs and incidence of dementia: the Rotterdam study. Neurobiol Aging 2001; 22: 407-412
80. Kornhube HH. Präventive Neurologie. Nervenarzt 1983; 54: 57-68
81. Wolozin B, Kellman W, Rousseau P et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl coencyme A reductase inhibitors. Arch Neurol 2000; 57: 1439-1443
82. Jick H, Zornberg GL, Jick SS et al. Statins and the risk of dementia. Lancet 2000; 356: 1627-1631
83. Cucchiara B, Kasner SE. Use of statins in CNS disorders. J Neurol Sci 2001; 187: 81-89
84. Marks J. Bad for the heart, bad for the mind? High cholesterol levels may foster the brain degeneration of Alzheimer's raising the possibility that cholesterol-lowering drugs will protect against the disease. Science 2001; 294: 508-509
85. Sheperd J, Blauw GJ, Murphy MB et al. (PROSPER study group) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 2002; 360: 1623-1630
86. GISSI-prevenzione investigators. Dietary supplementation with n-3-polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet 1999; 354: 447-455
87. McGeer PL, Akyama H, Itagaki S et al. Activation of the classic complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 1989; 107: 341-346
88. Miklossy J, Casas S, Janzer RC et al. Further ultrastructural evidence that spirochaetes may play a role in the aetiology of Alzheimer's disease. NeuroReport 1994; 5: 1201-1204
89. Howard J, Pilkington GJ. Fibronectin staining detects micro-organisms in aged and Alzheimer's disease brain. NeuroReport 1992; 3: 615-618
90. Balin BJ, Gerard HC, Arking EJ et al. Identification and localization of chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol (Berl) 1998; 187: 23-42
91. Stephenson J. New studies illuminate brain disorders. J Am Med Ass 1999; 281: 499-501
92. Kira J, Hamada T, Kawano Y et al. An association of human T-cell lymphotropic virus type I infection with vascular dementia. Acta Neurol Scand 1997; 96: 305-309
93. Zimmer C. Do chronic diseases have an infections root? Science 2001; 293: 1974-1977
94. Kornhuber HH. Propionibacterium acnes in the cortex of patients with Alzheimer's disease. EurArch Psychiat clin Neurosci 1996; 246: 108-109
95. Breitner JC. Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol Aging 1996; 17: 789-794
96. Evans DA, Hebert LE, Beckett CA et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol 1997; 54: 1399-1404
97. Wilson RS, de Mendes Leon CF, Barnes LL et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. J Am Med Ass 2002; 287: 742-748
98. Wilson RS, Bennett DA, Bienias JL et al. Cognitive activity and incident AD in a population based sample of older persons. Neurology 2002; 59: 1910-1914
99. Vergese J, Lipton RB, Katz MJ et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003; 348: 2508-2516
100. Brezinka W. Die Pädagogik der neuen Linken. 6. Aufl. Basel: E. Reinhard, 1981
101. Kornhuber HH. Evolution des Gehirns und Persönlichkeit: Frontalhirn, Ethos, Hedonismus. In: Gross G, Huber G, Morgner J (Hrsg). Persönlichkeit, Persönlichkeitsstörung, Psychose. Stuttgart, New York: Schattauer, 1996: 219-225
102. Noelle-Neumann E. Die Entdeckung des Wertewandels. In: Noelle-Neumann E, Köcher R (Hrsg). Allensbacher Jahrbuch der Demoskopie 1993-1997. München: KG Saur, 1997: 120-132
103. Csikszentmihalyi M. Flow- the psychology of optimal experience. New York: Harper & Row, 1990
104. Kornhuber HH. Über Auslösung cyklothymer Depressionen durch seelische Erschütterungen. Arch Psychiat Z Neurol 1955; 193: 391-405
105. Mäkinen IH. Eastern European transition and suicide mortality. Soc Sci and Med 2000; 51: 1405-1420
106. Kornhuber HH, Riebler R. Mit der Multiplen Sklerose leben. Die häusliche Behandlung der MS. Stuttgart, New York: Schattauer, 1984